Annual Operating Profit
-$167.54 M
-$59.83 M-55.55%
December 31, 2023
Summary
- As of February 8, 2025, KROS annual operating income is -$167.54 million, with the most recent change of -$59.83 million (-55.55%) on December 31, 2023.
- During the last 3 years, KROS annual operating profit has fallen by -$123.34 million (-279.08%).
- KROS annual operating profit is now -12582.89% below its all-time high of -$1.32 million, reached on December 31, 2018.
Performance
KROS Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$58.66 M
-$8.22 M-16.29%
September 30, 2024
Summary
- As of February 8, 2025, KROS quarterly operating income is -$58.66 million, with the most recent change of -$8.22 million (-16.29%) on September 30, 2024.
- Over the past year, KROS quarterly operating profit has dropped by -$14.60 million (-33.14%).
- KROS quarterly operating profit is now -2480.60% below its all-time high of -$2.27 million, reached on June 30, 2019.
Performance
KROS Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$201.63 M
-$15.38 M-8.26%
September 30, 2024
Summary
- As of February 8, 2025, KROS TTM operating income is -$201.63 million, with the most recent change of -$15.38 million (-8.26%) on September 30, 2024.
- Over the past year, KROS TTM operating profit has dropped by -$34.09 million (-20.35%).
- KROS TTM operating profit is now -7429.28% below its all-time high of -$2.68 million, reached on March 31, 2019.
Performance
KROS TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
KROS Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -55.5% | -33.1% | -20.4% |
| 3 y3 years | -279.1% | -190.4% | -223.4% |
| 5 y5 years | -10000.0% | -2421.8% | -1915.3% |
KROS Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -197.2% | at low | -1105.5% | at low | -257.7% | at low |
| 5 y | 5-year | -1574.6% | at low | -2050.2% | at low | -1915.3% | at low |
| alltime | all time | <-9999.0% | at low | -2480.6% | at low | -7429.3% | at low |
Keros Therapeutics Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$58.66 M(+16.3%) | -$201.63 M(+8.3%) |
| Jun 2024 | - | -$50.44 M(+4.0%) | -$186.26 M(+5.1%) |
| Mar 2024 | - | -$48.48 M(+10.1%) | -$177.16 M(+5.7%) |
| Dec 2023 | -$167.54 M(+55.5%) | -$44.05 M(+1.8%) | -$167.54 M(+7.8%) |
| Sep 2023 | - | -$43.28 M(+4.7%) | -$155.45 M(+13.9%) |
| Jun 2023 | - | -$41.34 M(+6.3%) | -$136.44 M(+11.4%) |
| Mar 2023 | - | -$38.87 M(+21.6%) | -$122.45 M(+13.7%) |
| Dec 2022 | -$107.71 M(+91.1%) | -$31.96 M(+31.7%) | -$107.71 M(+33.6%) |
| Sep 2022 | - | -$24.27 M(-11.3%) | -$80.61 M(+5.3%) |
| Jun 2022 | - | -$27.35 M(+13.4%) | -$76.54 M(+18.2%) |
| Mar 2022 | - | -$24.13 M(+395.8%) | -$64.73 M(+14.8%) |
| Dec 2021 | -$56.37 M | -$4.87 M(-75.9%) | -$56.37 M(-9.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$20.20 M(+30.0%) | -$62.34 M(+15.3%) |
| Jun 2021 | - | -$15.54 M(-1.4%) | -$54.09 M(+9.4%) |
| Mar 2021 | - | -$15.77 M(+45.6%) | -$49.46 M(+11.9%) |
| Dec 2020 | -$44.20 M(+341.7%) | -$10.83 M(-9.3%) | -$44.20 M(+22.4%) |
| Sep 2020 | - | -$11.95 M(+9.5%) | -$36.09 M(+36.3%) |
| Jun 2020 | - | -$10.91 M(+3.9%) | -$26.47 M(+48.5%) |
| Mar 2020 | - | -$10.50 M(+285.0%) | -$17.83 M(+78.2%) |
| Dec 2019 | -$10.01 M(+657.4%) | -$2.73 M(+17.3%) | -$10.01 M(+37.5%) |
| Sep 2019 | - | -$2.33 M(+2.3%) | -$7.28 M(+47.0%) |
| Jun 2019 | - | -$2.27 M(-15.1%) | -$4.95 M(+84.9%) |
| Mar 2019 | - | -$2.68 M | -$2.68 M |
| Dec 2018 | -$1.32 M | - | - |
FAQ
- What is Keros Therapeutics annual operating income?
- What is the all time high annual operating profit for Keros Therapeutics?
- What is Keros Therapeutics annual operating profit year-on-year change?
- What is Keros Therapeutics quarterly operating income?
- What is the all time high quarterly operating profit for Keros Therapeutics?
- What is Keros Therapeutics quarterly operating profit year-on-year change?
- What is Keros Therapeutics TTM operating income?
- What is the all time high TTM operating profit for Keros Therapeutics?
- What is Keros Therapeutics TTM operating profit year-on-year change?
What is Keros Therapeutics annual operating income?
The current annual operating profit of KROS is -$167.54 M
What is the all time high annual operating profit for Keros Therapeutics?
Keros Therapeutics all-time high annual operating income is -$1.32 M
What is Keros Therapeutics annual operating profit year-on-year change?
Over the past year, KROS annual operating income has changed by -$59.83 M (-55.55%)
What is Keros Therapeutics quarterly operating income?
The current quarterly operating profit of KROS is -$58.66 M
What is the all time high quarterly operating profit for Keros Therapeutics?
Keros Therapeutics all-time high quarterly operating income is -$2.27 M
What is Keros Therapeutics quarterly operating profit year-on-year change?
Over the past year, KROS quarterly operating income has changed by -$14.60 M (-33.14%)
What is Keros Therapeutics TTM operating income?
The current TTM operating profit of KROS is -$201.63 M
What is the all time high TTM operating profit for Keros Therapeutics?
Keros Therapeutics all-time high TTM operating income is -$2.68 M
What is Keros Therapeutics TTM operating profit year-on-year change?
Over the past year, KROS TTM operating income has changed by -$34.09 M (-20.35%)